Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00132444 · ClinicalTrials.gov registry record · Phase 1
Study of UC-781 Vaginal Microbicide
A Phase 1 study, sponsored by CONRAD.
- Completed
- Registry status
- Phase 1
- Development phase
- 90
- Enrollment target
NCT00132444 is a Phase 1 study that has completed, run by CONRAD. The registered enrollment target is 90 participants.
The verdict
NCT00132444, a Phase 1 study, has completed, sponsored by CONRAD.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 90 participants
- Enrollment target
Study Summary
This study will help determine whether the agent UC-781, formulated as a gel, is safe when applied to the vagina twice daily for 14 days. It will also assess whether women find the gel acceptable to use.
Interventions
- DRUG topical vaginal application of UC-781 gel
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2005-10 |
| Est. Completion | 2008-12 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00132444
The ClinicalTrials.gov registry entry for NCT00132444 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is CONRAD, which has 33 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which topical vaginal application of UC-781 gel is the first listed.
NCT00132444 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00132444 about?
NCT00132444 is a clinical study titled "Study of UC-781 Vaginal Microbicide". This study will help determine whether the agent UC-781, formulated as a gel, is safe when applied to the vagina twice daily for 14 days. It will also assess whether women find the gel acceptable to use.
What is the current status of trial NCT00132444?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 90 participants. The study started on 2005-10. Estimated completion is 2008-12.
What interventions are being tested in trial NCT00132444?
The interventions under investigation include: topical vaginal application of UC-781 gel (DRUG).
Who is sponsoring clinical trial NCT00132444?
This trial is sponsored by CONRAD, which has 33 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.